>> AI ALLIANCE RP > AI RESEARCH > AI PROJECTS > AI-CARE: ARTIFICIAL INTELLIGENCE FOR TREATING CANCER THERAPY RESISTANCE
AI-Care: Artificial Intelligence for treating cancer therapy resistance
- Duration: 01.04.2024 - 31.03.2030
Funding Organization: Carl-Zeiss-Stiftung
Prof. Dr. Marius Kloft
University of Kaiserslautern-LandauArtificial Intelligence for treating cancer therapy resistance
In pharmaceutical research, the early detection of undesirable or even absent effects of therapeutics represents the greatest hurdle to successful.
To achieve a breakthrough in the treatment of brain tumors, an AI-based model for the interplay of gene activity and therapy response is being developed.
The goal is to predict the effect of drugs and optimize personalized therapies for cancer patients.
https://www.carl-zeiss-stiftung.de/en/project-overview/detail/artificial-intelligence-for-treating-cancer-therapy-resistance-ai-care
AI Focus Areas of the Research Project
Basic Research
- Machine Learning (ML): Self-Supervised Learning, Reinforcement Learning (RL)